Variant report
Variant | nsv1033892 |
---|---|
Chromosome Location | chr9:17734224-17757581 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:147)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr9:17741979-17742453 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr9:17734741-17734980 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr9:17734858-17734892 | HepG2 | liver: | n/a | n/a |
4 | CREB1 | chr9:17742071-17742365 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CREB1 | chr9:17742042-17742527 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CTCF | chr9:17742200-17742350 | A549 | lung: | n/a | n/a |
7 | CTCF | chr9:17742160-17742310 | NHEK | skin: | n/a | n/a |
8 | CTCF | chr9:17742240-17742390 | BE2_C | brain: | n/a | n/a |
9 | CTCF | chr9:17742180-17742330 | Hela-S3 | cervix: | n/a | n/a |
10 | CTCF | chr9:17742148-17742385 | Hela-S3 | cervix: | n/a | n/a |
11 | CTCF | chr9:17742060-17742210 | HFF-Myc | foreskin: | n/a | n/a |
12 | CTCF | chr9:17742140-17742290 | HRE | kidney: | n/a | n/a |
13 | CTCF | chr9:17742120-17742270 | HBMEC | blood vessel: | n/a | n/a |
14 | CTCF | chr9:17742236-17742351 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | CTCF | chr9:17744480-17744630 | GM12868 | blood: | n/a | n/a |
16 | CTCF | chr9:17742140-17742290 | HFF | foreskin: | n/a | n/a |
17 | CTCF | chr9:17742220-17742370 | BJ | skin: | n/a | n/a |
18 | CTCF | chr9:17742200-17742350 | HFF-Myc | foreskin: | n/a | n/a |
19 | CTCF | chr9:17742223-17742330 | Fibrobl | skin: | n/a | n/a |
20 | CTCF | chr9:17742245-17742330 | A549 | lung: | n/a | n/a |
21 | CTCF | chr9:17742160-17742310 | HMF | breast: | n/a | n/a |
22 | CTCF | chr9:17742200-17742350 | Hela-S3 | cervix: | n/a | n/a |
23 | CTCF | chr9:17742100-17742250 | HPAF | blood vessel: | n/a | n/a |
24 | CTCF | chr9:17742120-17742270 | MCF-7 | breast: | n/a | n/a |
25 | CTCF | chr9:17742220-17742370 | HEK293 | kidney: | n/a | n/a |
26 | CTCF | chr9:17742009-17742399 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | CTCF | chr9:17742160-17742310 | HCT-116 | colon: | n/a | n/a |
28 | CTCF | chr9:17742220-17742370 | RPTEC | kidney: | n/a | n/a |
29 | CTCF | chr9:17742180-17742330 | WERI-Rb-1 | eye: | n/a | n/a |
30 | CTCF | chr9:17742200-17742350 | WERI-Rb-1 | eye: | n/a | n/a |
31 | CTCF | chr9:17742180-17742330 | SK-N-SH_RA | brain: | n/a | n/a |
32 | CTCF | chr9:17742160-17742310 | HPF | lung: | n/a | n/a |
33 | CTCF | chr9:17742140-17742290 | HA-sp | spinal cord: | n/a | n/a |
34 | CTCF | chr9:17742140-17742290 | HBMEC | blood vessel: | n/a | n/a |
35 | CTCF | chr9:17742175-17742363 | Gliobla | brain: | n/a | n/a |
36 | CTCF | chr9:17742180-17742330 | RPTEC | kidney: | n/a | n/a |
37 | CTCF | chr9:17742235-17742315 | ProgFib | skin: | n/a | n/a |
38 | CTCF | chr9:17742180-17742306 | HepG2 | liver: | n/a | n/a |
39 | CTCF | chr9:17742200-17742350 | BJ | skin: | n/a | n/a |
40 | CTCF | chr9:17742160-17742310 | HRPEpiC | eye: | n/a | n/a |
41 | CTCF | chr9:17742140-17742290 | HCFaa | heart: | n/a | n/a |
42 | CTCF | chr9:17742160-17742310 | HMEC | breast: | n/a | n/a |
43 | CTCF | chr9:17742200-17742350 | HEK293 | kidney: | n/a | n/a |
44 | CTCF | chr9:17742160-17742310 | AG09319 | gingival: | n/a | n/a |
45 | CTCF | chr9:17742200-17742350 | BE2_C | brain: | n/a | n/a |
46 | CTCF | chr9:17748980-17749130 | GM12869 | blood: | n/a | n/a |
47 | CTCF | chr9:17742100-17742250 | AG09309 | skin: | n/a | n/a |
48 | CTCF | chr9:17742180-17742330 | SAEC | small airway: | n/a | n/a |
49 | CTCF | chr9:17752876-17752965 | Kidney_OC | kidney: | n/a | n/a |
50 | CTCF | chr9:17742200-17742350 | NHEK | skin: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SH3GL2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10963233 | chr9:17734771-17734772 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs116013194 | chr9:17734786-17734787 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs10963234 | chr9:17734788-17734789 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs541217601 | chr9:17734809-17734810 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs138340657 | chr9:17734864-17734865 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs4961590 | chr9:17734890-17734891 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs186935891 | chr9:17734907-17734908 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs4961445 | chr9:17734938-17734939 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs551936219 | chr9:17734952-17734953 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs190870072 | chr9:17734966-17734967 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs534853810 | chr9:17734969-17734970 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs546811446 | chr9:17734972-17734973 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs373855188 | chr9:17734985-17734986 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs115039606 | chr9:17734997-17734998 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs562695408 | chr9:17735004-17735005 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs183239834 | chr9:17735015-17735016 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs554972152 | chr9:17735041-17735042 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs572775683 | chr9:17735053-17735054 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs542069776 | chr9:17735068-17735069 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs4961446 | chr9:17735083-17735084 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs537561940 | chr9:17735090-17735091 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs546724239 | chr9:17735102-17735103 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs138576156 | chr9:17735601-17735602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557406954 | chr9:17735607-17735608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149290271 | chr9:17735634-17735635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545840105 | chr9:17735677-17735678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565955677 | chr9:17735701-17735702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2383044 | chr9:17735707-17735708 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs528218279 | chr9:17735713-17735714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75865686 | chr9:17735723-17735724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561931441 | chr9:17735729-17735730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529117183 | chr9:17735737-17735738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558060114 | chr9:17735760-17735761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535466442 | chr9:17735767-17735768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182870033 | chr9:17735773-17735774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573206217 | chr9:17735806-17735807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569087192 | chr9:17735830-17735831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533040904 | chr9:17735833-17735834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552167659 | chr9:17735834-17735835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547342695 | chr9:17735836-17735837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372143472 | chr9:17735843-17735844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570484507 | chr9:17735844-17735845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144555973 | chr9:17735848-17735849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147997030 | chr9:17735859-17735860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142461275 | chr9:17735864-17735865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535720052 | chr9:17735865-17735866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs4515654 | chr9:17735870-17735871 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs575865443 | chr9:17735901-17735902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1536066 | chr9:17735905-17735906 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs372462000 | chr9:17735933-17735934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 22183965 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Thoracic aortic aneurysm | 21698135 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Ovarian cancer | 19835627 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:17735600-17736400 | Enhancers | Fetal Brain Male | brain |
2 | chr9:17736400-17737600 | Weak transcription | Fetal Brain Male | brain |
3 | chr9:17737600-17737800 | Enhancers | Fetal Brain Male | brain |
4 | chr9:17737800-17738400 | Weak transcription | Fetal Brain Male | brain |
5 | chr9:17738400-17740000 | Enhancers | Fetal Brain Male | brain |
6 | chr9:17739200-17741800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr9:17741200-17742400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr9:17741600-17742200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr9:17741800-17742200 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr9:17741800-17742200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr9:17741800-17742200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr9:17741800-17742400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
13 | chr9:17741800-17742600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr9:17741800-17742600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr9:17742200-17742400 | Enhancers | Gastric | stomach |
16 | chr9:17742400-17742800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
17 | chr9:17742800-17743000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
18 | chr9:17743000-17743800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
19 | chr9:17743800-17744000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
20 | chr9:17744000-17750200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
21 | chr9:17744800-17745000 | Enhancers | Gastric | stomach |
22 | chr9:17749400-17750200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
23 | chr9:17750000-17750800 | Enhancers | Brain Germinal Matrix | brain |
24 | chr9:17750200-17750800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
25 | chr9:17750800-17751800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
26 | chr9:17752000-17752200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
27 | chr9:17754800-17772600 | Weak transcription | Hela-S3 | cervix |
28 | chr9:17757400-17757800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |